Goodheart MJ - Search Results

1

A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Martin LP, Sill M, Shahin MS, Powell M, DiSilvestro P, Landrum LM, Gaillard SL, Goodheart MJ, Hoffman J, Schilder RJ. Martin LP, et al. Among authors: goodheart mj. Gynecol Oncol. 2014 Mar;132(3):526-30. doi: 10.1016/j.ygyno.2013.12.018. Epub 2013 Dec 18. Gynecol Oncol. 2014. PMID: 24361733 Free PMC article. Clinical Trial.

2

Ovarian cancer p53 mutation is associated with tumor microvessel density.

Goodheart MJ, Vasef MA, Sood AK, Davis CS, Buller RE. Goodheart MJ, et al. Gynecol Oncol. 2002 Jul;86(1):85-90. doi: 10.1006/gyno.2002.6730. Gynecol Oncol. 2002. PMID: 12079305

3

The influence of microvessel density on ovarian carcinogenesis.

Stone PJ, Goodheart MJ, Rose SL, Smith BJ, DeYoung BR, Buller RE. Stone PJ, et al. Among authors: goodheart mj. Gynecol Oncol. 2003 Sep;90(3):566-71. doi: 10.1016/s0090-8258(03)00367-6. Gynecol Oncol. 2003. PMID: 13678725

4

Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer.

Jacobson GM, Kamath RS, Smith BJ, Goodheart MJ. Jacobson GM, et al. Among authors: goodheart mj. Gynecol Oncol. 2005 Feb;96(2):470-4. doi: 10.1016/j.ygyno.2004.10.023. Gynecol Oncol. 2005. PMID: 15661237

5

Thromboembolic events in patients with cervical carcinoma: Incidence and effect on survival.

Jacobson G, Lammli J, Zamba G, Hua L, Goodheart MJ. Jacobson G, et al. Among authors: goodheart mj. Gynecol Oncol. 2009 May;113(2):240-4. doi: 10.1016/j.ygyno.2009.01.021. Epub 2009 Feb 28. Gynecol Oncol. 2009. PMID: 19251310

6

A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival.

Shamshirsaz AA, Buekers T, Degeest K, Bender D, Zamba G, Goodheart MJ. Shamshirsaz AA, et al. Among authors: goodheart mj. Int J Gynecol Cancer. 2011 Oct;21(7):1232-40. doi: 10.1097/IGC.0b013e318220fc46. Int J Gynecol Cancer. 2011. PMID: 21720254

7

Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer.

Nadkarni NJ, Geest KD, Neff T, Young BD, Bender DP, Ahmed A, Smith BJ, Button A, Goodheart MJ. Nadkarni NJ, et al. Among authors: goodheart mj. Cancer Lett. 2013 Apr 30;331(1):99-104. doi: 10.1016/j.canlet.2012.12.016. Epub 2012 Dec 23. Cancer Lett. 2013. PMID: 23268330

8

Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis.

Clevenger L, Schrepf A, Degeest K, Bender D, Goodheart M, Ahmed A, Dahmoush L, Penedo F, Lucci J 3rd, Thaker PH, Mendez L, Sood AK, Slavich GM, Lutgendorf SK. Clevenger L, et al. Cancer. 2013 Sep 1;119(17):3234-41. doi: 10.1002/cncr.28188. Epub 2013 Jun 24. Cancer. 2013. PMID: 23797955 Free PMC article.

9

Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients.

Lutgendorf SK, Slavich GM, Degeest K, Goodheart M, Bender D, Thaker PH, Penedo F, Zimmerman B, Lucci J 3rd, Mendez L, Collins K, Sood AK. Lutgendorf SK, et al. Gynecol Oncol. 2013 Dec;131(3):667-73. doi: 10.1016/j.ygyno.2013.09.025. Epub 2013 Oct 3. Gynecol Oncol. 2013. PMID: 24096110 Free PMC article.

10

Intra-operative frozen section results reliably predict final pathology in endometrial cancer.

Stephan JM, Hansen J, Samuelson M, McDonald M, Chin Y, Bender D, Reyes HD, Button A, Goodheart MJ. Stephan JM, et al. Among authors: goodheart mj. Gynecol Oncol. 2014 Jun;133(3):499-505. doi: 10.1016/j.ygyno.2014.03.569. Epub 2014 Apr 1. Gynecol Oncol. 2014. PMID: 24699308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters